
Please try another search
Cassiopea S.p.A. is a specialty pharmaceutical company that focuses on the development and commercialization of medical dermatology products worldwide. It offers Winlevi, a topical androgen receptor inhibitor for the treatment of acne vulgaris; Breezula, an androgen receptor inhibitor that targets androgen receptors in the scalp; CB-06-01, a topical antibiotic, which is in Phase II clinical trial for the treatment of acne, including strains resistant to other antibiotics; and CB-06-02, a novel integrin activator that has completed Phase II clinical trial to treat genital warts. Cassiopea S.p.A. was formerly known as Cosmo Dermatos S.r.l. The company was founded in 2013 and is based in Lainate, Italy. Cassiopea S.p.A. operates as a subsidiary of Cosmo Pharmaceuticals N.V.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review